Priest J R, Robison L L, McKenna R W, Lindquist L L, Warkentin P I, LeBien T W, Woods W G, Kersey J H, Coccia P F, Nesbit M E
Blood. 1980 Jul;56(1):15-22.
In a 3-yr period, the Philadelphia chromosome (Ph1) was found in 4 of 43 children with acute lymphoblastic leukemia (ALL) in whom chromosomes were studied at diagnosis. The clinical, morphological, cytochemical, and immunologic findings in the Ph1-positive (PH1+) CASES WERE CONsistent with typical childhood ALL, indicating that identification of cases requires chromosome studies. A review of all reported cases of Ph1 + childhood ALL shows that Ph1 + patients are older and have higher initial platelet and white blood cell counts (WBC) than most children with ALL. However, a life table comparison between the reported cases of Ph1 + ALL in children and randomly selected age-, sex-, and WBC-matched controls with ALL shows the duration of first marrow remission to be significantly shorter (p less than 0.02) for the Ph1 + cases Ph1 + ALL is a distinct subtype of childhood ALL that is not rare and can be identified only by cytogenetic studies. The prognosis is poor. Cytogenetic studies should be done prospectively in a large group of children with ALL to define further the subgroup of patients and to confirm the findings of this retrospective analysis.
在3年期间,对43例急性淋巴细胞白血病(ALL)患儿进行了诊断时的染色体研究,其中4例发现有费城染色体(Ph1)。Ph1阳性(PH1+)病例的临床、形态学、细胞化学和免疫学表现与典型的儿童ALL一致,这表明病例的识别需要进行染色体研究。对所有已报道的Ph1+儿童ALL病例的回顾显示,Ph1+患者比大多数ALL儿童年龄更大,初始血小板和白细胞计数(WBC)更高。然而,对已报道的儿童Ph1+ ALL病例与随机选择的年龄、性别和WBC匹配的ALL对照进行生命表比较,结果显示Ph1+病例的首次骨髓缓解期明显更短(p小于0.02)。Ph1+ ALL是儿童ALL的一种独特亚型,并不罕见,且只能通过细胞遗传学研究来识别。其预后较差。应前瞻性地对一大组ALL患儿进行细胞遗传学研究,以进一步明确患者亚组,并证实这项回顾性分析的结果。